Shopping Cart 0
Cart Subtotal
USD 0

Ophthalmic Viscoelastic Devices (OVD)-Medical Devices Pipeline Assessment, 2017

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Ophthalmic Viscoelastic Devices (OVD)-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Ophthalmic Viscoelastic Devices (OVD)-Medical Devices Pipeline Assessment, 2017" provides an overview of Ophthalmic Viscoelastic Devices (OVD) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Viscoelastic Devices (OVD) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Ophthalmic Viscoelastic Devices (OVD) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Ophthalmic Viscoelastic Devices (OVD) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Ophthalmic Viscoelastic Devices (OVD) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 4

2 Introduction 5

2.1 Ophthalmic Viscoelastic Devices (OVD) Overview 5

3 Products under Development 6

3.1 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 6

3.2 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Segment 7

3.3 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Territory 8

3.4 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Regulatory Path 9

3.5 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Estimated Approval Date 10

4 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products under Development by Companies 11

4.1 Ophthalmic Viscoelastic Devices (OVD) Companies-Pipeline Products by Stage of Development 11

4.2 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 12

5 Ophthalmic Viscoelastic Devices (OVD) Companies and Product Overview 13

5.1 EyeKon Medical Inc Company Overview 13

5.1.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Shanghai Haohai Biological Technology Co Ltd Company Overview 30

5.2.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.3 Valeant Pharmaceuticals International Inc Company Overview 31

5.3.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 31

6 Appendix 32

6.1 Methodology 32

6.2 About GlobalData 35

6.3 Contact Us 35

6.4 Disclaimer 35


List Of Figure

1.2 List of Figures

Figure 1: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 6

Figure 2: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Segment 7

Figure 3: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Territory 8

Figure 4: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Regulatory Path 9

Figure 5: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Estimated Approval Date 10


List Of Table

1.1 List of Tables

Table 1: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 6

Table 2: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Segment 7

Table 3: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Territory 8

Table 4: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Regulatory Path 9

Table 5: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Estimated Approval Date 10

Table 6: Ophthalmic Viscoelastic Devices (OVD) Companies-Pipeline Products by Stage of Development 11

Table 7: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 12

Table 8: EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 13

Table 9: AcuGel Plus Viscoelastics-Product Status 14

Table 10: AcuGel Plus Viscoelastics-Product Description 14

Table 11: AcuGel SH Viscoelastics-Product Status 14

Table 12: AcuGel SH Viscoelastics-Product Description 15

Table 13: AcuGel Viscoelastics-Product Status 15

Table 14: AcuGel Viscoelastics-Product Description 15

Table 15: Acurus Gel-Product Status 16

Table 16: Acurus Gel-Product Description 16

Table 17: Acurus Gel Plus-Product Status 16

Table 18: Acurus Gel Plus-Product Description 17

Table 19: Acurus SH-Product Status 17

Table 20: Acurus SH-Product Description 17

Table 21: Cirrus Biogel Plus-Product Status 18

Table 22: Cirrus Biogel Plus-Product Description 18

Table 23: Cirrus Biogel SH-Product Status 18

Table 24: Cirrus Biogel SH-Product Description 19

Table 25: DR Gel-Product Status 19

Table 26: DR Gel-Product Description 19

Table 27: DR Gel Plus-Product Status 20

Table 28: DR Gel Plus-Product Description 20

Table 29: DR Gel SH-Product Status 20

Table 30: DR Gel SH-Product Description 21

Table 31: EyeCoat Plus Viscoelastic-Product Status 21

Table 32: EyeCoat Plus Viscoelastic-Product Description 21

Table 33: EyeCoat SH Viscoelastic-Product Status 22

Table 34: EyeCoat SH Viscoelastic-Product Description 22

Table 35: EyeCoat Viscoelastic-Product Status 22

Table 36: EyeCoat Viscoelastic-Product Description 23

Table 37: Isogel-Product Status 23

Table 38: Isogel-Product Description 23

Table 39: Isogel Plus-Product Status 24

Table 40: Isogel Plus-Product Description 24

Table 41: Isogel SH-Product Status 24

Table 42: Isogel SH-Product Description 25

Table 43: MD Gel-Product Status 25

Table 44: MD Gel-Product Description 25

Table 45: MD Gel Plus-Product Status 26

Table 46: MD Gel Plus-Product Description 26

Table 47: MD Gel SH-Product Status 26

Table 48: MD Gel SH-Product Description 27

Table 49: Suncoast Gel Viscoelastics-Product Status 27

Table 50: Suncoast Gel Viscoelastics-Product Description 27

Table 51: Suncoast Plus Viscoelastics-Product Status 28

Table 52: Suncoast Plus Viscoelastics-Product Description 28

Table 53: Suncoast SH Viscoelastics-Product Status 28

Table 54: Suncoast SH Viscoelastics-Product Description 29

Table 55: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Table 56: QST Gel-OVD-Product Status 30

Table 57: QST Gel-OVD-Product Description 30

Table 58: Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 59: Ophthalmic Viscosurgical Device-Product Status 31

Table 60: Ophthalmic Viscosurgical Device-Product Description 31

Table 61: Glossary 34

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

EyeKon Medical Inc, AcuGel Plus Viscoelastics; EyeKon Medical Inc, AcuGel SH Viscoelastics; EyeKon Medical Inc, AcuGel Viscoelastics; EyeKon Medical Inc, Acurus Gel; EyeKon Medical Inc, Acurus Gel Plus; EyeKon Medical Inc, Acurus SH; EyeKon Medical Inc, Cirrus Biogel Plus; EyeKon Medical Inc, Cirrus Biogel SH; EyeKon Medical Inc, DR Gel; EyeKon Medical Inc, DR Gel Plus; EyeKon Medical Inc, DR Gel SH; EyeKon Medical Inc, EyeCoat Plus Viscoelastic; EyeKon Medical Inc, EyeCoat SH Viscoelastic; EyeKon Medical Inc, EyeCoat Viscoelastic; EyeKon Medical Inc, Isogel; EyeKon Medical Inc, Isogel Plus; EyeKon Medical Inc, Isogel SH; EyeKon Medical Inc, MD Gel; EyeKon Medical Inc, MD Gel Plus; EyeKon Medical Inc, MD Gel SH; EyeKon Medical Inc, Suncoast Gel Viscoelastics; EyeKon Medical Inc, Suncoast Plus Viscoelastics; EyeKon Medical Inc, Suncoast SH Viscoelastics; Shanghai Haohai Biological Technology Co Ltd, QST Gel-OVD; Valeant Pharmaceuticals International Inc, Ophthalmic Viscosurgical Device


Companies

EyeKon Medical Inc

Shanghai Haohai Biological Technology Co Ltd

Valeant Pharmaceuticals International Inc

Ophthalmic Viscoelastic Devices (OVD)-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Ophthalmic Viscoelastic Devices (OVD)-Medical Devices Pipeline Assessment, 2017" provides an overview of Ophthalmic Viscoelastic Devices (OVD) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Viscoelastic Devices (OVD) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Ophthalmic Viscoelastic Devices (OVD) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Ophthalmic Viscoelastic Devices (OVD) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Ophthalmic Viscoelastic Devices (OVD) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 4

2 Introduction 5

2.1 Ophthalmic Viscoelastic Devices (OVD) Overview 5

3 Products under Development 6

3.1 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 6

3.2 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Segment 7

3.3 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Territory 8

3.4 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Regulatory Path 9

3.5 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Estimated Approval Date 10

4 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products under Development by Companies 11

4.1 Ophthalmic Viscoelastic Devices (OVD) Companies-Pipeline Products by Stage of Development 11

4.2 Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 12

5 Ophthalmic Viscoelastic Devices (OVD) Companies and Product Overview 13

5.1 EyeKon Medical Inc Company Overview 13

5.1.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 Shanghai Haohai Biological Technology Co Ltd Company Overview 30

5.2.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.3 Valeant Pharmaceuticals International Inc Company Overview 31

5.3.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 31

6 Appendix 32

6.1 Methodology 32

6.2 About GlobalData 35

6.3 Contact Us 35

6.4 Disclaimer 35


List Of Figure

1.2 List of Figures

Figure 1: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 6

Figure 2: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Segment 7

Figure 3: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Territory 8

Figure 4: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Regulatory Path 9

Figure 5: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Estimated Approval Date 10


List Of Table

1.1 List of Tables

Table 1: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 6

Table 2: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Segment 7

Table 3: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Territory 8

Table 4: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Regulatory Path 9

Table 5: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Estimated Approval Date 10

Table 6: Ophthalmic Viscoelastic Devices (OVD) Companies-Pipeline Products by Stage of Development 11

Table 7: Ophthalmic Viscoelastic Devices (OVD)-Pipeline Products by Stage of Development 12

Table 8: EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 13

Table 9: AcuGel Plus Viscoelastics-Product Status 14

Table 10: AcuGel Plus Viscoelastics-Product Description 14

Table 11: AcuGel SH Viscoelastics-Product Status 14

Table 12: AcuGel SH Viscoelastics-Product Description 15

Table 13: AcuGel Viscoelastics-Product Status 15

Table 14: AcuGel Viscoelastics-Product Description 15

Table 15: Acurus Gel-Product Status 16

Table 16: Acurus Gel-Product Description 16

Table 17: Acurus Gel Plus-Product Status 16

Table 18: Acurus Gel Plus-Product Description 17

Table 19: Acurus SH-Product Status 17

Table 20: Acurus SH-Product Description 17

Table 21: Cirrus Biogel Plus-Product Status 18

Table 22: Cirrus Biogel Plus-Product Description 18

Table 23: Cirrus Biogel SH-Product Status 18

Table 24: Cirrus Biogel SH-Product Description 19

Table 25: DR Gel-Product Status 19

Table 26: DR Gel-Product Description 19

Table 27: DR Gel Plus-Product Status 20

Table 28: DR Gel Plus-Product Description 20

Table 29: DR Gel SH-Product Status 20

Table 30: DR Gel SH-Product Description 21

Table 31: EyeCoat Plus Viscoelastic-Product Status 21

Table 32: EyeCoat Plus Viscoelastic-Product Description 21

Table 33: EyeCoat SH Viscoelastic-Product Status 22

Table 34: EyeCoat SH Viscoelastic-Product Description 22

Table 35: EyeCoat Viscoelastic-Product Status 22

Table 36: EyeCoat Viscoelastic-Product Description 23

Table 37: Isogel-Product Status 23

Table 38: Isogel-Product Description 23

Table 39: Isogel Plus-Product Status 24

Table 40: Isogel Plus-Product Description 24

Table 41: Isogel SH-Product Status 24

Table 42: Isogel SH-Product Description 25

Table 43: MD Gel-Product Status 25

Table 44: MD Gel-Product Description 25

Table 45: MD Gel Plus-Product Status 26

Table 46: MD Gel Plus-Product Description 26

Table 47: MD Gel SH-Product Status 26

Table 48: MD Gel SH-Product Description 27

Table 49: Suncoast Gel Viscoelastics-Product Status 27

Table 50: Suncoast Gel Viscoelastics-Product Description 27

Table 51: Suncoast Plus Viscoelastics-Product Status 28

Table 52: Suncoast Plus Viscoelastics-Product Description 28

Table 53: Suncoast SH Viscoelastics-Product Status 28

Table 54: Suncoast SH Viscoelastics-Product Description 29

Table 55: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Table 56: QST Gel-OVD-Product Status 30

Table 57: QST Gel-OVD-Product Description 30

Table 58: Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Table 59: Ophthalmic Viscosurgical Device-Product Status 31

Table 60: Ophthalmic Viscosurgical Device-Product Description 31

Table 61: Glossary 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

EyeKon Medical Inc, AcuGel Plus Viscoelastics; EyeKon Medical Inc, AcuGel SH Viscoelastics; EyeKon Medical Inc, AcuGel Viscoelastics; EyeKon Medical Inc, Acurus Gel; EyeKon Medical Inc, Acurus Gel Plus; EyeKon Medical Inc, Acurus SH; EyeKon Medical Inc, Cirrus Biogel Plus; EyeKon Medical Inc, Cirrus Biogel SH; EyeKon Medical Inc, DR Gel; EyeKon Medical Inc, DR Gel Plus; EyeKon Medical Inc, DR Gel SH; EyeKon Medical Inc, EyeCoat Plus Viscoelastic; EyeKon Medical Inc, EyeCoat SH Viscoelastic; EyeKon Medical Inc, EyeCoat Viscoelastic; EyeKon Medical Inc, Isogel; EyeKon Medical Inc, Isogel Plus; EyeKon Medical Inc, Isogel SH; EyeKon Medical Inc, MD Gel; EyeKon Medical Inc, MD Gel Plus; EyeKon Medical Inc, MD Gel SH; EyeKon Medical Inc, Suncoast Gel Viscoelastics; EyeKon Medical Inc, Suncoast Plus Viscoelastics; EyeKon Medical Inc, Suncoast SH Viscoelastics; Shanghai Haohai Biological Technology Co Ltd, QST Gel-OVD; Valeant Pharmaceuticals International Inc, Ophthalmic Viscosurgical Device


Companies

EyeKon Medical Inc

Shanghai Haohai Biological Technology Co Ltd

Valeant Pharmaceuticals International Inc